Related Experiment Video
Updated: May 3, 2026

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde
Published on: November 11, 2022
A Nanocomposite Dynamic Covalent Cross-Linked Hydrogel Loaded with Fusidic Acid for Treating Antibiotic-Resistant
Samaneh Toufanian1, Jody Mohammed2, Erica Winterhelt3
1Department of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is associated with high levels of morbidity and is considered a difficult-to-treat infection, often requiring nonstandard treatment regimens and antibiotics. Since over 40% of the emerging antibiotic compounds have insufficient solubility that limits their bioavailability and thus efficacy through oral or intravenous administration, it is crucial that alternative drug delivery products be developed for wound care applications. Existing effective treatments for soft tissue MRSA infections, such as fusidic acid (FA), which is typically administered orally, could also benefit from alternative routes of administration to improve local efficacy and bioavailability while reducing the required therapeutic dose. Herein, we report an antimicrobial poly(oligoethylene glycol methacrylate) (POEGMA)-based composite hydrogel loaded with fusidic acid-encapsulating self-assembled polylactic acid-b-poly(oligo(ethylene glycol) methyl ether methacrylate) (PLA-POEGMA) nanoparticles for the treatment of MRSA-infected skin wounds. The inclusion of the self-assembled nanoparticles (380 nm diameter when loaded with fusidic acid) does not alter the favorable mechanical properties and stability of the hydrogel in the context of its use as a wound dressing, while fusidic acid (FA) can be released from the hydrogel over ∼10 h via a diffusion-controlled mechanism. The antimicrobial studies demonstrate a clear zone of inhibition in vitro and a 1-2 order of magnitude inhibition of bacterial growth in vivo in an MRSA-infected full-thickness excisional murine wound model even at very low antibiotic doses. Our approach thus can both circumvent challenges in the local delivery of hydrophobic antimicrobial compounds and directly deliver antimicrobials into the wound to effectively combat methicillin-resistant infections using a fraction of the drug dose required using other clinically relevant strategies.
Insights
A novel hydrogel loaded with fusidic acid nanoparticles effectively treats MRSA skin infections. This approach improves local drug delivery and reduces antibiotic dosage for better wound care outcomes.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Drug Delivery Systems
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infections cause significant morbidity and are challenging to treat.
- Many new antibiotics have poor solubility, limiting their effectiveness via standard administration routes.
- Existing treatments like fusidic acid (FA) could be improved with alternative delivery methods for better local efficacy.
Purpose of the Study:
- To develop an advanced wound dressing for treating MRSA infections.
- To overcome challenges in delivering hydrophobic antimicrobial drugs locally.
- To enhance the bioavailability and reduce the dosage of fusidic acid for skin wound treatment.
Main Methods:
- Fabrication of a poly(oligoethylene glycol methacrylate) (POEGMA) composite hydrogel.
- Encapsulation of fusidic acid (FA) within polylactic acid-b-poly(oligo(ethylene glycol) methyl ether methacrylate) (PLA-POEGMA) nanoparticles.
- Loading of FA-encapsulating nanoparticles into the hydrogel for sustained release (approx. 10 hours).
- Evaluation of hydrogel mechanical properties and stability.
- In vitro and in vivo assessment of antimicrobial activity against MRSA in a murine wound model.
Main Results:
- The composite hydrogel maintained favorable mechanical properties and stability.
- Fusidic acid was released via a diffusion-controlled mechanism over ~10 hours.
- Demonstrated significant in vitro zones of inhibition against MRSA.
- Achieved 1-2 orders of magnitude reduction in bacterial growth in vivo in MRSA-infected wounds.
- Effective treatment was observed even at very low antibiotic doses.
Conclusions:
- The developed POEGMA hydrogel loaded with FA-encapsulating nanoparticles is a promising strategy for MRSA wound infections.
- This approach effectively delivers hydrophobic antimicrobials locally, improving efficacy and reducing required drug dosage.
- The system circumvents bioavailability issues associated with poorly soluble antibiotics.
More Related Videos
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Microbial Corrosion
iChip
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

